Charles River Associates at Sidoti conference: growth, AI and talent

Charles River Associates said 2026 revenue is up more than 13% year to date, extending eight consecutive years of record top-line growth and exceeding the roughly 6% increase in relevant Lex Machina case filings. The debt-free consultancy reported its highest profit year on an EBITDA-plus-non-cash-amortization basis, with adjusted operating cash flow equivalent to about 112% of EBITDA, while repurchasing more than $180 million of stock over five years and cutting its share count by over 15%. Management views AI as a demand and productivity catalyst, while data-center-driven utility investment is creating its strongest practice-level demand surge in energy consulting. Growth remains constrained principally by competition for senior revenue-generating talent, particularly in Europe.

Analysis

CRAI’s investable distinction is not simply consulting demand but its ability to convert scarce senior-expert capacity into high incremental-margin revenue while retiring a meaningful portion of the equity base. That model supports per-share earnings compounding if utilization remains high, but it also makes the stock unusually sensitive to a small number of rainmaker departures or expensive lateral hires; the relevant KPI is revenue per billable professional and compensation/revenue, not headline organic growth.

The underappreciated catalyst is the intersection of data-center power buildout and state-level utility-rate proceedings. CRAI can monetize both sides of the power-capacity bottleneck—utilities seeking cost recovery and hyperscalers seeking siting/rate optimization—creating a less cyclical growth vector than transaction-related antitrust work. This should also be read through to utility capex beneficiaries (ETN, PWR, GEV), although rate-case friction can delay returns and raise political risk for regulated utilities.

Near term, a small-cap conference is unlikely to change institutional estimates without subsequent quarterly evidence that utilization, pricing and hiring are holding. Over 1-3 months, earnings revisions could follow if energy-practice growth translates into broader margin expansion; over 6-18 months, sustained share gains and continued buybacks could warrant a premium to smaller advisory peers. The contrarian issue is that management’s cash-profit framing adds back compensation-like talent consideration: economically, recurring renewals for senior producers are a real cost even if accounting treatment is non-cash, so valuation should be anchored to GAAP EPS and free cash flow after normalized talent investment rather than adjusted EBITDA alone.

Thesis fails if voluntary senior attrition rises, compensation/revenue increases materially, or growth decelerates toward the underlying litigation/M&A activity level without offsetting energy revenue. A reversal in data-center construction, weaker M&A closings, or a sharp regulatory easing in Europe would reduce project intensity; conversely, more state intervention in large mergers may offset softer federal enforcement.

Key Decisions for Investors

• Initiate a starter long CRAI only on confirmation from the next earnings release that revenue growth remains above 10% and GAAP operating margin expands year over year; target a 12-18 month holding period. Size modestly given key-person concentration and limited liquidity, with a 15% drawdown or two consecutive quarters of declining utilization as a review trigger.
• Use CRAI as a quality small-cap compounder rather than a conference-driven momentum trade: add on post-earnings weakness if management maintains hiring returns and buyback pace while GAAP EPS estimates hold. Expected return depends on earnings compounding plus modest multiple expansion; avoid underwriting management’s non-GAAP cash metric at face value.
• For data-center power exposure, prefer a basket of ETN/PWR/GEV over regulated-utility longs; CRAI is a differentiated, smaller ancillary beneficiary. Reassess the theme if hyperscaler capex guidance is cut or interconnection timelines materially lengthen.
• Do not trade PSKY on this item. Its mention is tied to a transaction example rather than a disclosed CRAI revenue exposure, and there is insufficient evidence to infer a material financial linkage.